Peter A. Gottlieb - Researcher Profile

Publications

2 shown

An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes

Kevan C. Herold , Brian N. Bundy , S. Alice Long +18 more

Teplizumab delayed progression to clinical type 1 diabetes in high-risk participants. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT0103...

2019 New England Journal of Medicine 989 citations

Genetic Predictors of Response to Oral Insulin for Type 1 Diabetes Prevention

Hemang Parikh , Taylor M. Triolo , Lauric Ferrat +6 more

OBJECTIVE The TrialNet Oral Insulin Prevention Trial TN07 tested oral insulin to prevent stage 3 type 1 diabetes (T1D) in 560 relatives with stage 1 T1D of individuals with T1D....

2025 Diabetes Care 0 citations

Frequent Co-Authors

Researcher Info

h-index: 1
Publications: 2
Citations: 989
Institution: University of Colorado Anschutz Medical Campus

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-7601-8536

Impact Metrics

h-index 1

h-index: Number of publications with at least h citations each.